PNC Managed Account Solutions’s Bristol-Myers Squibb BMY Stock Holding History

PNC Managed Account Solutions’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$37K	Buy	+548	New	+$35.7K	0.01%	391

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

PNC Managed Account Solutions's BMY Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in Bristol-Myers Squibb (BMY) in Q2 2021: 548 shares worth $37K. The stake represents 0.01% of the portfolio and ranks #391 among its holdings.

2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

PNC Managed Account Solutions held 548 shares of Bristol-Myers Squibb worth $37K as of Q2 2021.
Bristol-Myers Squibb was a new PNC Managed Account Solutions position in Q2 2021.
Bristol-Myers Squibb made up 0.01% of PNC Managed Account Solutions's portfolio in Q2 2021, its #391 holding.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.